Fundraising FoxFountain Healthcare Partners — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Veliceptvelicept.comJul 2018
Biotechnology company developing products for overactive bladder and irritable bowel syndrome.
BiotechMalvern, US
Douglas Gessl(Executive Officer)inJames Walker(Executive Officer, Director)in
BoardScott Morenstein(Director)David Hirsch(Director)James Bennethum(Director)Stephen Tullman(Director)
Co-investorsLongitude CapitalSamsara BioCapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.